Advice on the treatment of symptomatic and asymptomatic E. histolytica infection is beyond the scope of this site and in any case should be provided by the individual's personal physician. However, for those interested in clinical diagnosis and treatment, information can be found in the following three publications:
Pillai, D.R., Keystone, J.S. & Kain, K.C. (2000) Treatment. In J. I. Ravdin (ed.), Amebiasis. London: Imperial College Press, pp. 127-136.
Ravdin, J.I. (1995) Amebiasis (Review). Clin. Infect. Dis. 20: 1453-1466.
Reed, S.L. (1992) Amebiasis: an update. Clin. Infect. Dis. 14: 385-393.
Based on these and other recent publications the usual drug regimens recommended are:
| |||
(luminal infection only) | |||
(Diiodohydroxyquin) | |||
OR 30 mg/kg/day in 3 doses, 5-10 days | |||
(Note) | OR 50 mg/kg, 1 dose | 86% | |
(Note) | OR 2.4 g q.d., 1-2 days | ||
Note: Treatment of invasive amoebiasis should ALWAYS be followed up with treatment for lumenal parasites as these are not eliminated by the drug regimen for invasive disease in many cases.